FDA panel endorses Pfizer booster shots for elderly, high-risk

The FDA advisory panel voted to recommend Pfizer booster shots for people 65 and over and others at higher risk of serious illness. It was the first vaccine to be authorized for emergency use and was used in the earliest stages of America's vaccination program. But the FDA is saying the boosters are not for everybody. Michael George reports.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting